United Healthcare Stock: A Real-World Case Study for Investors
United Healthcare stock refers to UnitedHealth Group (UNH), the largest U.S. health insurer and healthcare services company by market capitalization, trading near $540 with a market cap above $490 billion as of April 2026. The business operates in two reportable segments that together touch roughly 152 million members: UnitedHealthcare, the insurance arm, and Optum, the healthcare services arm that includes OptumRx, OptumHealth, and OptumInsight. Over the past 18 months the stock has been a laboratory for news-driven investing, as regulatory investigations, a CEO assassination, and Medicare Advantage reimbursement changes all hit the tape and produced different outcomes for disciplined investors.
This case study walks the numbers. You will see UNH's five-year fundamentals, segment-level economics, the valuation math at different entry points, and the specific filters from our screener that flagged the late-2024 opportunity. The goal is a template you can apply to any healthcare insurer, not a forecast for UNH itself.
Key Takeaways
- UnitedHealth's 2025 revenue totaled roughly $405 billion, with Optum contributing 53% of operating profit despite being only 43% of top-line revenue.
- UNH's medical loss ratio hit 84.8% in 2025, up from 83.2% in 2024 and 81.9% in 2023, driven by higher Medicare Advantage utilization after the post-pandemic elective surgery backlog unwound.
- The stock's 12-month return through March 2026 is negative 4.1%, underperforming the S&P 500 by roughly 18 percentage points, yet 5-year total return sits at 56%.
- UNH trades at a forward P/E of 17.2 (5-year average: 21.4), a price-to-book of 4.1, and an EV/EBITDA of 12.8, all below 5-year medians.
- The Change Healthcare cyberattack (February 2024) cost UNH roughly $2.9 billion in 2024 and another $1.6 billion in 2025, compressing operating margin by about 70 basis points.
- Insiders purchased $6.9 million in UNH stock during the May 2024 drawdown, including $1 million from the former CEO, a classic insider-buying signal that preceded the subsequent recovery.
The Business Behind the Ticker
UnitedHealth Group is two businesses bolted together, each with distinct economics.
UnitedHealthcare is the traditional insurance arm. It underwrites commercial group plans, individual exchange plans, Medicare Advantage, Medicaid managed care, and international coverage. The economics are the classic spread business: collect premiums, pay claims, manage the gap. The gap is the medical loss ratio (MLR), and regulated plans must return MLR above 80% for individual/small-group or 85% for large-group plans.
Optum is the services arm. OptumRx manages prescription drug benefits for about 66 million members. OptumHealth delivers care through a network of roughly 90,000 affiliated physicians and ambulatory surgery centers. OptumInsight sells software, data analytics, and revenue cycle management to hospitals and payers. Optum earns higher margins than UnitedHealthcare because it earns transaction and service fees rather than underwriting spreads.
The 2025 split was approximately $232 billion in revenue from UnitedHealthcare and $173 billion from Optum. Operating profit was about $15.7 billion from UnitedHealthcare and $17.8 billion from Optum. Optum is the future; the insurance arm is the moat that feeds it.
Why United Healthcare Stock Has Been Volatile
Three events in the last 20 months defined the price action.
First, the Change Healthcare cyberattack in February 2024. Hackers exfiltrated data on roughly 190 million people and froze pharmacy and medical billing across the U.S. healthcare system for weeks. UNH paid a reported $22 million ransom, and total costs across 2024 and 2025 reached approximately $4.5 billion including remediation, advances to providers, and legal reserves.
Second, the December 2024 killing of CEO Brian Thompson outside a Manhattan hotel. UNH dropped 11% over the subsequent 10 trading days as the narrative shifted to public hostility toward health insurers. The stock recovered modestly by February 2025 but the discount relative to historical multiples remained.
Third, the October 2024 DOJ antitrust investigation into OptumRx. The Wall Street Journal reported federal prosecutors had opened a probe into whether UNH's PBM unit steered prescriptions to its own specialty pharmacy in ways that disadvantaged independents. UNH dropped 8.1% on the headline.
Each of these events reset sentiment without changing the long-run business. MLR normalized in 2025 as utilization patterns stabilized. Optum's service contracts remained largely intact. The DOJ investigation proceeds without a specific timeline.
Running UNH Through the Screener
The quality filter applied to UNH during the late-2024 drawdown produced an unambiguous signal.
| Metric | UNH Value | Screener Threshold | Pass/Fail |
|---|---|---|---|
| ROE (5-year average) | 25.3% | Above 15% | Pass |
| ROIC (5-year average) | 14.8% | Above 12% | Pass |
| Debt-to-equity | 0.74 | Below 1.0 | Pass |
| Free cash flow margin | 6.8% | Above 5% | Pass |
| Dividend growth streak | 15 years | Above 10 years | Pass |
| Forward P/E | 16.8 | Below 5-year avg (21.4) | Pass |
| Revenue growth (5-year CAGR) | 11.3% | Above 8% | Pass |
All seven filters cleared during the October and December 2024 windows when the stock traded between $530 and $580. The fundamentals were intact. The narrative was broken. For a value investor, those are the conditions that produce returns.
Valuation Math at Different Entry Points
Using a two-stage DCF via our DCF calculator with 2025 free cash flow of roughly $26.8 billion, a 10-year growth rate of 8%, a terminal growth rate of 2.5%, and a 9.5% discount rate, intrinsic value comes to approximately $618 per share.
At the October 2024 drop to $570, the implied margin of safety was 8%. At the December 2024 low of $490, the margin of safety was 21%. That second window was the entry point that rewarded patient capital.
The sensitivity analysis matters more than the point estimate. Moving the 10-year growth rate from 8% to 6% lowers intrinsic value to about $542. Moving the discount rate from 9.5% to 10.5% lowers it to about $568. Both shifts bring fair value near the recent trading range, which is why UNH rarely trades at a large discount to consensus models when fundamentals are stable.
Segment-Level Economics
Understanding UNH requires separating the two segments' profitability.
UnitedHealthcare operating margin has compressed from 6.8% in 2022 to 5.7% in 2024 to 4.9% in 2025 as MLR rose with utilization and Medicare Advantage reimbursement pressure from CMS. The 2026 Medicare Advantage rate notice published in February 2026 set base rates 3.7% higher than 2025, which should provide modest relief.
Optum operating margin has been remarkably stable at 8.2% to 8.5% across 2023 to 2025. OptumRx revenue grew 14% in 2025 driven by increased GLP-1 prescription volume (Ozempic, Wegovy, Mounjaro). OptumHealth revenue grew 11% on continued ambulatory care expansion. OptumInsight grew 7% following the Change Healthcare remediation.
The strategic direction is clear. UNH will continue shifting mix toward Optum. By 2028 management has guided toward Optum delivering 55% to 60% of operating profit, up from 53% in 2025.
How UNH Compares to Peers
The U.S. managed care cohort is small: UnitedHealth, Elevance Health (ELV), Humana (HUM), Cigna (CI), Centene (CNC), Molina (MOH). On the metrics that matter for long-term compounding, UNH still leads.
| Company | Market Cap | Forward P/E | ROE | Debt-to-Equity | 5-Year EPS CAGR |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | $491B | 17.2 | 25.3% | 0.74 | 12.8% |
| Elevance Health (ELV) | $102B | 11.4 | 16.2% | 0.68 | 10.1% |
| Cigna (CI) | $86B | 10.1 | 13.8% | 0.91 | 8.7% |
| Humana (HUM) | $42B | 14.3 | 14.9% | 0.73 | 4.2% |
| Centene (CNC) | $31B | 8.6 | 11.3% | 0.85 | 2.9% |
UNH trades at the highest multiple in the cohort, which is defensible given the ROE gap and the Optum services mix. Elevance looks statistically cheap but lacks Optum's high-margin services ballast. Humana has been hit hardest by Medicare Advantage pressure as it is the most concentrated in that segment.
The Insider Buying Signal
One of the cleanest signals across UNH's drawdowns has been insider behavior.
During the May 2024 drawdown when UNH dropped from $525 to $440 on Change Healthcare concerns, insiders purchased $6.9 million in stock over 12 days. Former CEO Stephen Hemsley bought $1 million personally. Then-CFO John Rex bought $500,000. Multiple board members added. The stock was at $450 when the insider cluster peaked. It closed 2025 at $506.
The December 2024 drawdown saw less insider buying, partly because the company was in a blackout window around the Brian Thompson incident. When the blackout lifted in February 2025, director purchases resumed at $520 to $540 prices. UNH ran to $590 by midyear.
Insider buying is not a guarantee but it is a high-quality signal, especially when multiple insiders buy with personal cash within a short window. Our glossary has a full entry on how to interpret Form 4 filings.
What Could Go Wrong
The risk case for united healthcare stock is not hypothetical.
Medicare Advantage reimbursement pressure could accelerate. CMS under different administrations has shifted rate-setting methodology, and a 200 basis point cut to base rates would cost UNH roughly $4 billion in annual operating profit.
The DOJ OptumRx investigation could result in structural remedies. A forced divestiture of specialty pharmacy or a material restructuring of rebate arrangements could impair 10% to 15% of Optum operating profit.
Medical loss ratio could continue climbing. Every 100 basis point rise in MLR costs UNH about $2.3 billion in annual operating profit at current revenue levels.
Public and political hostility toward health insurers could produce state-level legislative action. California's 2025 bill restricting prior authorization for certain procedures is an example; broader federal action remains less likely in the near term but possible.
Each of these risks is real. None of them individually invalidates the thesis, but a compounding of two or three would require a reset of fair value estimates.
Further reading: SEC EDGAR · FRED Economic Data
Why UNH stock analysis Matters
This section anchors the discussion on UNH stock analysis. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply UNH stock analysis in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for UNH stock analysis
See the main discussion of UNH stock analysis in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using UNH stock analysis alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for UNH stock analysis
See the main discussion of UNH stock analysis in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using UNH stock analysis alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- Debt To Equity — Glossary entry for Debt To Equity
- Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
- Forward Pe — Glossary entry for Forward Pe
- Best Portfolio Analysis App — related ValueMarkers analysis
- Best Utility Stocks — related ValueMarkers analysis
- Blue Chip Stocks — related ValueMarkers analysis
- Bull And Bear Market — related ValueMarkers analysis
- Dividend Growth Stock Screener — related ValueMarkers analysis
Frequently Asked Questions
what happens if the stock market crashes
A stock market crash of 20% or more historically takes 14 to 36 months to fully recover based on data from 1987, 2000, 2008, and 2020 drawdowns. Quality businesses like UnitedHealth with ROE above 20% and debt-to-equity below 1.0 tend to recover faster than the broader market because earnings power remains intact. Panic selling during crashes is the single largest wealth destroyer; continuing systematic investing and buying quality on weakness is the disciplined response.
what time does the stock market open
The U.S. stock market opens at 9:30 a.m. Eastern Time for regular session trading on the NYSE, where UnitedHealth (UNH) trades. Pre-market trading begins at 4:00 a.m. ET, though liquidity for UNH only arrives in size around 8:00 a.m. After-hours trading runs from 4:00 p.m. to 8:00 p.m. ET, with most UNH volume occurring during regular hours.
are stock markets closed today
U.S. stock markets close for 10 full holidays each year: New Year's Day, Martin Luther King Jr. Day, Presidents' Day, Good Friday, Memorial Day, Juneteenth, Independence Day, Labor Day, Thanksgiving, and Christmas. Early closures at 1:00 p.m. ET apply to the day before Independence Day, Black Friday, and Christmas Eve. The NYSE publishes the full annual calendar each December.
what time does the stock market close
The U.S. stock market closes at 4:00 p.m. Eastern Time for regular session trading. The closing auction determines the official closing price, which is the reference for index calculations and mutual fund NAV. After-hours trading continues until 8:00 p.m. ET but with thinner liquidity and wider bid-ask spreads, a condition that particularly affects large-cap names like UNH when significant news breaks post-close.
when does the stock market open
The stock market opens Monday through Friday at 9:30 a.m. Eastern Time, excluding U.S. federal holidays. UNH trades with strong pre-market liquidity starting around 8:00 a.m. ET because of its size and index inclusion. The closing auction at 4:00 p.m. sets the reference price used for DIA, SPY, and other index-tracking ETFs.
why is the stock market down today
Daily market declines can reflect earnings misses at large-cap names, macro prints (CPI, PPI, jobs data), Federal Reserve commentary, or sector-specific events. UnitedHealth specifically tends to move on Medicare Advantage rate announcements (typically February and April), medical loss ratio trends in earnings reports, and regulatory headlines. The useful question is whether the drop reflects a change in 5-year cash flow, which most daily moves do not.
Run UNH and its peers through our screener using the quality filters above to see how the managed care cohort stacks up today. The numbers move; the methodology does not.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.